Oxford Endovascular, a British MedTech company and spin-out from Oxford University developing a treatment for brain aneurysms that will overcome challenges with existing medical devices, has raised USD10 million in a series A funding round
The raise follows on from previous non-dilutive grant funding won, including EUR3 million from the European Union’s prestigious Horizon 2020 SME Instrument and GBP350,000 from Innovate UK, the UK’s innovation agency Smart Grant program. During the Covid-19 crisis in 2020 the company was also one of only seven start-ups across Europe & Israel that won funding in return for options, to the tune of EUR500,000.
Source: Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.